Every year, over 46,500,000 people die worldwide from diseases.

Inefficiencies in clinical trials add significant time and cost to bring lifesaving drugs and therapies to market.

By introducing efficiencies to the clinical research model, PCRS helps reduce delays and, ultimately, save and improve lives.

PCRS Network consists of top performing Phase I, II, III, and IV sites strategically located throughout the U.S.

The combination of high quality, high productivity, and increased efficiency make for a winning combination for the Sponsor, CRO, and Site.



Only the best, most productive clinical research sites meet our requirements . . .

  • Members are accepted into the network through a rigorous qualification process

  • Historically high enrollment, retention, completion, and evaluable data rates

  • Centralized budget and contract processes result in time and cost savings

  • Prompt turnaround times on regulatory submissions and data entry

  • Continuous review of site quality and productivity metrics